Navigation Links
Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
Date:9/30/2009

2009.

Filgrastim is a granulocyte colony-stimulating factor (G-CSF) used to treat neutropenia, a condition in which the body makes too few infection-fighting white blood cells. The condition is often caused by drugs prescribed for cancer treatment.

Hospira's pegfilgrastim would be a biogeneric version of Amgen's Neulasta,® a second-generation G-CSF also used to treat neutropenia. Hospira intends to launch its biogeneric pegfilgrastim in Europe, Asia and the United States prior to the expiry of patents relating to Neulasta, and is conducting the requisite clinical work to support these regulatory submissions. Hospira also intends to register the Croatian plant and an existing Hospira facility in Australia as global sites of manufacture for pegfilgrastim.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has approximately 14,000 employees. Learn more at www.hospira.com.

                Private Securities Litigation Reform Act of 1995 --
                  A Caution Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to Hospira's biogenerics program, statements related to an intended launch date, and other statements regarding Hospira's goals and strategy. Hospira cautions that these forward-looking statements are s
'/>"/>

SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
2. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
3. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
4. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
5. U.S. Preventive Medicine Acquires Specialty Disease Management
6. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
7. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
8. PAREXEL Reaches Milestone in Management of Oncology Trials Over Last Five Years Involving 175,000 Patients Worldwide
9. Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System
10. Worldwide Sensation: "A"- Implant Novelty From Austria
11. Worldwide Cost Estimate for Alzheimers and Dementia Is US$315.4 Billion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... WASHINGTON , May 23, 2013  Vanda Pharmaceuticals Inc. ... company has been named the 2013 Life Science Firm of ... (TCM).  Vanda was honored at the TCM,s 25 ... Bethesda , Maryland.  The Tech Awards Celebration recognizes the ... in Maryland and the surrounding regions. ...
(Date:5/23/2013)... 23, 2013  Haemonetics Corporation (NYSE: HAE ) ... & EVP-Business Development, will present at The Deutsche Bank 38 ... Boston, MA on May 29, 2013 at 1:30pm ... The public may access Mr. Lindop,s presentation live ... Haemonetics Haemonetics (NYSE: HAE ) is ...
(Date:5/23/2013)... , May 23, 2013  A recently published clinical ... Houston, Texas , demonstrates that 3D mammography ... cancer detection. The study, "Implementation of ... Study," was led by Stephen L. Rose ... of the American Journal of Roentgenology (AJR). ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3
... Inc. (Nasdaq: STXS ) announced today that it had priced ... price to the public of $4.00 per share. Stereotaxis has ... to an additional 975,000 shares of common stock to cover over-allotments, ... being offered by Stereotaxis. Stereotaxis expects the offering to close ...
... VitalRemedyMD, a physician-established company, offers scientifically formulated ... of traditional healthcare. "We are proud that VitalProteinRx ... in helping patients with chronic kidney disease," stated ... medical food, VitalProteinRx is designed to provide highly ...
Cached Medicine Technology:Stereotaxis Announces Pricing of $26 Million Common Stock Offering 2Stereotaxis Announces Pricing of $26 Million Common Stock Offering 3Fresenius Medical Care, N.A. Has Selected VitalRemedyMD's VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients 2
(Date:5/24/2013)... minority parents have more realistic views about their ... vaccinating their daughters against the cervical cancer-causing human ... Conversely, white, middle-class parents are more likely to ... researchers from the Boston University School of Medicine. ... cancer each year, many of which can be ...
(Date:5/24/2013)... CA (PRWEB) May 24, 2013 American ... care education community, proudly participated in festivities surrounding the ... 19-21. The event provided the perfect backdrop to introduce ... at 236 E. 3rd Street, housed in an architectural ... Building. , ACC was an active exhibitor throughout the ...
(Date:5/24/2013)... The SunglassFIX Photo Contest lets ... while learning how to make their sunglasses, and ... only need to upload pictures of themselves, friends ... Sunglass Fix on Facebook in order to enter. ... lens replacement online store . , ...
(Date:5/24/2013)... Ore. A new discovery at Oregon Health & ... body effectively reacts when infected with the highly evasive ... researchers has been utilizing this unique approach to develop ... shown promising results in animal studies. This latest research ... edition of the journal Science . , ...
(Date:5/24/2013)... May 24, 2013 Residents of San ... boot camp classes. Fitness expert, and Certified Russian Kettlebell ... Kettlebell X Bootcamps in San Diego, California. The classes ... different class times offered. Initial sign-ups are available ... “I’ve been teaching Kettlebell for years. The bootcamps ...
Breaking Medicine News(10 mins):Health News:Low-Income, Minority Parents More Open to HPV Vaccine for Girls, Study Says 2Health News:American Career College Revs Up Community Support During Toyota Grand Prix of Long Beach 2Health News:Break the Sunglass Mold – Reuse 'Em, Don’t Toss 'Em then Enter the SunglassFIX Photo Contest to Win 2Health News:OHSU research highlights promising strategy to help vaccines outsmart HIV 2
... lab mice slows and may even halt the progress of ... back this tragic disease, US researchers report on Sunday. ... pressure, rejuvenated ageing dopamine cells, the brain cells whose death ... was so promising that the team now plan on conducting ...
... Veterans Disability Benefits Commission calls for an overhaul of the ... military veterans' disabilities to set payment levels. ,The ... Department to rate service members before they leave the military ... or diseases. The system was set up decades ago ...
... of Exeter has identified the role of the right side of ... strokes has furthered our understanding of the different roles of the ... focused on damage to the frontal lobes, the front part of ... language, decision making and learning. The team found that people who ...
... In a documented first -of -its-kind case, a teenager died ... aching muscles. , Arielle Newman, 17, from Staten Island, ... amount of methyl salicylate, the active ingredient found in such ... companies such as Johnson and Johnson produce such creams meant ...
... have finally found out how the Ice Age in Europe ... part of the research, the team of scientists from the ... of the West African monsoon yet, spanning 155,000 years and ... barium in plankton shells found in an ocean sediment core ...
... a glass of cider a day could keep the doctor ... fermented juices of apples or pears, is one of the ... in Britain but is now produced wherever apple cultivation is ... ,The drink is also popular in France, Ireland and ...
Cached Medicine News:Health News:Test Drug Seen as Best Hope in Decades for Tackling Parkinson's 2Health News:US Veteran Benefit System Needs Overhauling 2Health News:Right Side of Brain Play a Vital Role in Stroke 2Health News:American Sports Star Teenager Dies Due To Overdose Of Muscle Cream 2
... H-1200 Fast Flow Fluid Warmer, a new generation ... the existing Level 1 Fast Flow Fluid Warmer ... Fluid Warmer incorporates the features of integrated air ... deliver warm fluids as fast as 1,000 ml/minute ...
Futuremeds Astotherm Plus Blood and Fluid Warmers meet American Blood Bank and ECRI standards., ,Astotherm is a durable warmer you can rely on for many years....
... Flexible excellence for patients and clinicians., ... the Aestiva/5 anesthesia system, the Aestiva/5 MRI ... anesthesia systems with a fully functional, integrated ... (300 Gauss, 1.5 T active shielded magnet), ...
... meeting today's and tomorrow's needs in anesthesia procedures., ... solutions in its field today. This compact system ... revolving arm holds the complete user interface. A ... that there is less need to move the ...
Medicine Products: